CHINOOK THERAPEUTICS INC's ticker is KDNY and the CUSIP is 16961L106. A total of 158 filers reported holding CHINOOK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.03 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $1,899,331 | +122.1% | 49,436 | +33.8% | 0.01% | +66.7% |
| Q1 2023 | $855,115 | -20.4% | 36,938 | -9.9% | 0.00% | 0.0% |
| Q4 2022 | $1,074,148 | +36.3% | 40,998 | +2.2% | 0.00% | 0.0% |
| Q3 2022 | $788,000 | +6.6% | 40,106 | -5.1% | 0.00% | +50.0% |
| Q2 2022 | $739,000 | +11.0% | 42,278 | +3.9% | 0.00% | +100.0% |
| Q1 2022 | $666,000 | +0.3% | 40,700 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $664,000 | +27.9% | 40,700 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $519,000 | +11.6% | 40,700 | +23.6% | 0.00% | 0.0% |
| Q2 2021 | $465,000 | +67.3% | 32,924 | +83.9% | 0.00% | 0.0% |
| Q1 2021 | $278,000 | -5.8% | 17,900 | -3.8% | 0.00% | 0.0% |
| Q4 2020 | $295,000 | – | 18,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 5,161,888 | $135,241,466 | 29.11% |
| Octagon Capital Advisors LP | 2,551,703 | $66,854,619 | 10.41% |
| Affinity Asset Advisors, LLC | 818,035 | $21,432,517 | 8.40% |
| Frazier Life Sciences Management, L.P. | 4,345,559 | $113,853,646 | 7.08% |
| Saturn V Capital Management LP | 423,177 | $6,728,298 | 5.58% |
| Altium Capital Management LP | 385,000 | $10,087,000 | 5.13% |
| Deep Track Capital, LP | 3,000,000 | $78,600,000 | 3.30% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 340,389 | $8,914,788 | 2.75% |
| Vivo Capital, LLC | 872,151 | $22,850 | 2.63% |
| Nan Fung Group Holdings Ltd | 113,950 | $2,985,490 | 2.06% |